Novel Methods for Using Biomarkers to Monitor Glucose Levels and Screen for Diabetes Risk
- Early-stage
- In vitro data available
This technology describes a family of novel glycated peptide and protein biomarkers for glycemic control, as well as a method to monitor glycemic control in diabetic patients. In contrast to intracellular HbA1C, this technology detects glycated plasma proteins, which may reflect changes in glycemic control more rapidly and with more sensitivity. A diagnostic test developed using this technology could be envisioned to supplement or replace current HbA1C-based glycemic monitoring and screen individuals for risk of diabetes.
- Diagnostic test to measure glycemic control in diabetic patients
- Diagnostic test to screen patients for risk of developing diabetes
- Detects plasma proteins rather than intracellular markers
- May provide more rapid and sensitive detection than currently used methods